Central Nervous System (CNS) Drugs Market Research Report, Growth & Forecast

The global dementia drugs market size was valued at USD 20.98 Billion in 2025. Looking forward, IMARC Group estimates the market to reach USD 37.37 Billion by 2034, exhibiting a CAGR of 6.6% from 2026...

The Alcohol Addiction (AA) – Pipeline Insights – 2018 Size, Share, Industry, Forecast and outlook (2024-2031) was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The...

The Alzheimer’s Disease (AD) – Pipeline Insights – 2018 Size, Share, Industry, Forecast and outlook (2024-2031) was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. Th...

The Amyloid Protein Blockers – Pipeline Insights – 2018 Size, Share, Industry, Forecast and outlook (2024-2031) was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. Th...

The Bipolar Disorder (Manic Depression) – Pipeline Insight – 2018 Size, Share, Industry, Forecast and outlook (2024-2031) was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 t...

The global antipsychotic drugs market is forecast to grow at a CAGR of 6.5%, reaching USD 28.8 billion in 2031 from USD 21.0 billion in 2026. The antipsychotic drugs market plays a central role in the...

Anticonvulsants Marketis is growing with a CAGR of 2.20% during the forecast period 2026-2035. The Anticonvulsants Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where s...

The Cervical Dystonia Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to deliver unpara...

... from neurological disorders, including stroke, Alzheimer’s disease, epilepsy, Parkinson’s disease (PD), ... suffer from a traumatic central nervous system (CNS) injury each year ... disease. Neuroprotective agents in global markets and clinical pipelines include small molecule drugs, therapeutic monoclonal antibodies ...

Attention Deficit Hyperactivity Disorder (ADHD) Market reached US$ 16.23 billion in 2024 and is expected to reach US$ 27.04 billion by 2033, growing with a CAGR of 5.90% during the forecast period 202...

Benzodiazepine Drugs Marketis is growing with a CAGR of 2.29% during the forecast period 2026-2035. The Benzodiazepine Drugs Market emerges as a key focus in DataM Intelligence latest in-depth analysi...

HNY Research projects that the Narcolepsy Drug market size will grow from 3448.3 Million USD in 2025 to 6809.42 Million USD by 2031, at an estimated CAGR of 12.01%. The base year considered for the st...

The global insomnia market size was valued at USD 5.5 Billion in 2025. Looking forward, IMARC Group estimates the market to reach USD 6.8 Billion by 2034, exhibiting a CAGR of 2.45% during 2026-2034....

The Gabapentin Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to deliver unparalleled...

The Global Acute Migraine Drugs Market is projected to expand from USD 2.32 Billion in 2025 to USD 3.11 Billion by 2031, registering a CAGR of 5.01%. These pharmaceutical interventions are specificall...

The Global Risperidone Market is projected to expand from USD 6.36 Billion in 2025 to USD 8.58 Billion by 2031, reflecting a CAGR of 5.12%. As an atypical antipsychotic, risperidone is primarily emplo...

The Global CGRP Inhibitor Market is projected to expand from USD 3.62 Billion in 2025 to USD 6.32 Billion by 2031, achieving a CAGR of 9.73%. These inhibitors represent a specialized category of pharm...

The Global Insomnia Pharmacological Treatment Market is projected to expand from USD 4.03 Billion in 2025 to USD 5.63 Billion by 2031, reflecting a CAGR of 5.73%. This sector comprises a diverse array...

The Global Memory Enhancement Drugs Market is projected to expand from USD 7.32 Billion in 2025 to USD 9.93 Billion by 2031, registering a CAGR of 5.21%. This sector encompasses pharmaceutical product...

The Global Attention Deficit Hyperactivity Disorder (ADHD) Market is projected to expand from USD 17.82 Billion in 2025 to USD 23.25 Billion by 2031, registering a CAGR of 4.53%. This market encompass...

The Global Learning Disabilities Treatment Market is projected to expand from USD 21.43 Billion in 2025 to USD 31.16 Billion by 2031, registering a CAGR of 6.44%. This market comprises pharmaceutical...

The Global Schizophrenia Drugs Market is projected to expand from USD 6.45 Billion in 2025 to USD 8.48 Billion by 2031, registering a compound annual growth rate of 4.67%. This market encompasses a va...

The Global Epilepsy Drugs Market is projected to expand from USD 7.16 Billion in 2025 to USD 8.59 Billion by 2031, reflecting a CAGR of 3.08%. This industry sector encompasses the development and sale...

The Global Multiple System Atrophy Market is projected to expand from USD 154.39 Million in 2025 to USD 185.53 Million by 2031, reflecting a Compound Annual Growth Rate of 3.11%. This market involves...

The Global Post-traumatic Stress Disorder Treatment Market is projected to expand from USD 969.39 Million in 2025 to USD 1280.63 Million by 2031, registering a CAGR of 4.75% during the forecast period...

The Global Narcolepsy Therapeutics Market is projected to expand from a valuation of USD 3.42 Billion in 2025 to USD 5.09 Billion by 2031, reflecting a Compound Annual Growth Rate (CAGR) of 6.85%. The...

The Global Disruptive Behavior Disorder Treatment Market is projected to expand from USD 1.86 million in 2025 to USD 2.57 million by 2031, registering a compound annual growth rate of 5.54%. This mark...

The Global Alzheimer?s Therapeutics Market is projected to expand from USD 4.92 Billion in 2025 to USD 7.77 Billion by 2031, reflecting a compound annual growth rate (CAGR) of 7.92%. Alzheimer?s thera...

The Global Central Nervous System Therapeutics Market is projected to expand from USD 115.21 billion in 2025 to USD 182.42 billion by 2031, reflecting a CAGR of 7.96%. These therapeutics consist of ph...

The Global Lewy Body Dementia Treatment Market is projected to expand from USD 5.24 Billion in 2025 to USD 7.72 Billion by 2031, reflecting a compound annual growth rate of 6.67%. This market covers p...

The Complex Regional Pain Syndrome Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to d...

According to our (Global Info Research) latest study, the global Venlafaxine Hydrochloride Capsules market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by...

According to our (Global Info Research) latest study, the global Central Nervous System (CNS) Therapeutics market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ mil...

According to our (Global Info Research) latest study, the global Levodopa and Benserazide Hydrochloride Capsules market size was valued at US$ million in 2025 and is forecast to a readjusted size of U...

According to our (Global Info Research) latest study, the global Levodopa and Benserazide Hydrochloride Tablets market size was valued at US$ million in 2025 and is forecast to a readjusted size of US...

According to our (Global Info Research) latest study, the global Paroxetine Hydrochloride Enteric-coated Sustained-release Tablets market size was valued at US$ million in 2025 and is forecast to a re...

Huntington’s Disease Treatment Market is expected to grow at a 14.7% CAGR, achieving USD 2.129 billion in 2031 from USD 0.935 billion in 2025. The Huntington’s disease treatment market is positioned f...

Migraine Drugs Marketis is growing with a CAGR of 10.30% during the forecast period 2026-2035. The Migraine Drugs Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where se...

Dopamine Agonists Market reached US$ 1,148.88 Million in 2024 and is expected to reach US$ 1,732.41 Million by 2033, growing with a CAGR of 5.40% during the forecast period 2026-2033. The Dopamine Ago...

Antipsychotic Drugs Market reached US$ 16.41 Billion in 2024 and is expected to reach US$ 36.05 Billion by 2033, growing with a CAGR of 9.20% during the forecast period 2026-2033. The Antipsychotic Dr...

... study covers the world outlook for Lou Gehrig's Disease drugs across more than ... not discuss the specific players in the market serving the latent demand, nor specific ... the P.I.E., for Lou Gehrig's Disease drugs. It also shows how the P.I.E. is divided across the world's regional and national markets. For each ...

... Market Segment by Applications, can be divided into Daytime Extreme Sleepiness Cataplexia Others There are 15 Chapters to deeply display the global Narcolepsy Drug market. Chapter 1, to describe Narcolepsy Drug Introduction, product scope, market overview, market opportunities, market risk, market driving force; Chapter 2, to analyze the top manufacturers of Narcolepsy Drug, with ...

... and rising prevalence of lifestyle-associated CNS disorders are increasing global demand for CNS therapeutics. Mental health segment accounted for ... is expected to emerge as the fastest growing segment in the Central Nervous System therapeutics market. High demand for effective treatment and a large number ...

... manufacturers of Neuromyelitis Optica Drug, with price, sales, revenue and global market share of Neuromyelitis Optica Drug in 2017 and 2018. Chapter 3, the Neuromyelitis Optica Drug competitive situation, sales, revenue and global market share ...

This study covers the world outlook for CNS therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for...

HNY Research projects that the Insomnia Pharmacological Treatment market size will grow from 3189.54 Million USD in 2025 to 3980.41 Million USD by 2031, at an estimated CAGR of 3.76%. The base year co...

HNY Research projects that the Myasthenia Gravis Drugs market size will grow from 1682.12 Million USD in 2025 to 2799.9 Million USD by 2031, at an estimated CAGR of 8.86%. The base year considered for...

HNY Research projects that the Tauopathies Treatment market size will grow from 968.43 Million USD in 2025 to 1719.05 Million USD by 2031, at an estimated CAGR of 10.04%. The base year considered for...

HNY Research projects that the Traumatic Brain Injury Therapeutics market size will grow from 1007.87 Million USD in 2025 to 1277.39 Million USD by 2031, at an estimated CAGR of 4.03%. The base year c...

The global Narcolepsy Drug market size is expected to reach $ 7492 million by 2032, rising at a market growth of 10.3% CAGR during the forecast period (2026-2032). Narcolepsy is a long-term neurologic...